Impact of metabolic syndrome definitions on prevalence estimates: A study in a Portuguese community

Diabetes and Vascular Disease Research

Volumn 4, Issue 4, 2007, Pages 320-327

  Santos, Ana Cristina ^a   Barros, Henrique ^a  

^a University of Porto   (Portugal)

Author keywords

Definitions; Epidemiology; Metabolic syndrome; Prevalence

Indexed keywords

ADULT; AGED; ARTICLE; COMMUNITY; CONTROLLED STUDY; FEMALE; HEALTH EDUCATION; HISTORY OF MEDICINE; HUMAN; HYPERTENSION; INTERVIEW; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; AMERICAN HEART ASSOCIATION; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); PORTUGAL; SOCIETIES, MEDICAL; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 37849048244     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.3132/dvdr.2007.059     Document Type: Article

References (38)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
2. Grundy SM, Brewer B, Cleeman JI, Smith SC Jr, Lenfant C. Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004;109:433-8.
3. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-78.
4. Alberti K, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
5. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
6. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-22.
7. Alberti K, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469-80.
8. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
9. Laaksonen DE, Niskanen L, Lakka HM, Lakka TA, Uusitupa M. Epidemiology and treatment of the metabolic syndrome. Ann Med 2004;36:332-46.
10. Lakka H, Laaksonen D, Lakka T et al. The metabolic syndrome and total cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16.
11. Sattar N, Gaw A, Scherbakova O et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-19.
12. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-304.
13. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005;165:2644-50.
14. Martins I, Delfim Santos L, Gomes M, Machado I, Rocha E. 1° Relatório sobre a Qualidade de Vida Urbana - Porto. Porto: Câmara Municipal do Porto - Gabinete de Estudos e Planeamento; 2003.
15. Ramos E, Lopes C, Barros H. Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction. Ann Epidemiol 2004;14:437-41.
16. World Health Organization. Guidelines for ATC classification. Collaborating Centre for drug statistics methodology, Nordic Council on Medicines. Oslo: WHO; 1990.
17. Allain C, Poon L, Chan C et al. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
18. Bucolo G, David H. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem 1973;19:476-82.
19. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in men. Diabetologia 1985;28:412-19.
20. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999;16:442-3.
21. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
22. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004;33:351-75.
23. Skilton MR, Moulin P, Sérusclat A, Nony P, Bonnet F. A comparison of the NCEP-ATP III, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: evidence for sex-specific differences. Atherosclerosis 2007;190:416-22.
24. Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP. The prevalence of the metabolic syndrome using the National Cholesterol Education Program and International Diabetes Federation definitions. Curr Med Res Opin 2005;21:1157-9.
25. Bo S, Gentile L, Ciccone G et al. The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population based cohort. Diabetes Metab Res Rev 2005;21:515-24.
26. Villegas R, Perry IJ, Creagh D, Hinchion R, O'Halloran D. Prevalence of the metabolic syndrome in middle-aged men and women. Diabetes Care 2003;26:3198-9.
27. Onat A, Ceyhan K, Basar Ö, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels - a prospective and cross-sectional evaluation. Atherosclerosis 2002;165:285-92.
28. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005;28:2745-9.
29. DECODE Study Group. Prevalence of the metabolic syndrome in populations of Asian origin. Comparison of the IDF definition with the NCEP definition. Diabetes Res Clin Pract 2006;76:57-67.
30. DECODE Study Group, Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006;49:2837-46.
31. Assmann G, Guerra R, Fox G et al. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol 2007;99:541-8.
32. Cheung B, Ong K, Man Y, Wong L, Lau C, Lam K. Prevalence of the metabolic syndrome in the United States National Health and Nutrition Examination Survey 1999-2002 according to different defining criteria. J Clin Hypertens 2006;8:562-70.
33. Yoon Y, Lee E, Park C, Lee S, Oh S. The new definition of metabolic syndrome by the International Diabetes Federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised National Cholesterol Education Program: the Korea NHANES study. Int J Obes 2007;31:528-34.
34. Meigs J. Insulin resistance syndrome? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000;152:908-11.
35. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT et al. Central adiposity determines prevalence differences of the metabolic syndrome. Obes Res 2003;11:1480-7.
36. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: A prospective cohort study. Atherosclerosis 2007;191:182-90.
37. Rasouli N, Molavi B, Elbein SC, Kern PA. Ectopic fat accumulation and the metabolic syndrome. Diabetes Obes Metab 2007;9:1-10.
38. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004;164:1066-76.